Conventional and Alternative Pain Treatment Markets

Conventional and Alternative Pain Treatment Markets

Report Scope

This report covers the conventional and alternative pain treatments used by patients with chronic or acute pain. It provides the current and future market potential of conventional and alternative pain treatments and includes a detailed analysis of the competitive environment. The report covers the drivers, restraints and opportunities in the market; surveys the prevalence of or incidence of chronic diseases; and highlights emerging technologies for alternative treatment procedures. It includes market projections for 2029 and provides the market shares of key players.

In this analysis, the conventional and alternative pain treatment market is segmented based on pain management type into pharmaceuticals/drug therapy and devices. The pharmaceuticals/drug therapy segment is further segmented into non-narcotic analgesics, medical cannabis, narcotic analgesics, antimigraine agents, central nervous system (CNS) treatments, anesthetics, and other classes of pharmaceutical drug therapy. The devices segment of the conventional and alternative pain treatment market is further segmented into spine stimulators, electrotherapy/muscle stimulation, and other devices. Based on application, the overall conventional and alternative pain treatment market is segmented into orthopedic and musculoskeletal pain, general and broad pain management, surgical pain management, migraine/headache pain, neuropathic pain, cancer pain, fibromyalgia pain, and other pain types.

The overall conventional and alternative pain treatment market has also been segmented by geography into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa (MEA). Each regional analysis covers the region’s leading countries, namely, the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico and GCC countries. Market data is provided for 2023, which serves as the base year; estimates are given for 2024 and forecast values for 2029.

Report Includes

48 data tables and 56 additional tables

Analysis of the global market for conventional and alternative pain treatments

Analyses of global market trends, with market revenue data from 2012-2023, estimates for 2024, and projected CAGRs through 2029

Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by pain management type, application and region

Facts and figures pertaining to the market dynamics, technological advances, regulations, and the influence of macroeconomic factors

A Porter’s Five Forces analysis, a global supply chain analysis and a SWOT analysis

Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies

A look at recent patent grants

Analysis of the industry structure and competitive landscape, including company market shares, strategic alliances, M&A activity and venture funding outlook

Profiles of market leaders, including Medtronic, Abbott, GSK, Pfizer Inc., and Johnson & Johnson

Companies Mentioned

ABBOTT
ABBVIE INC.
AMGEN INC.
BAXTER
BAYER AG
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BOSTON SCIENTIFIC CORP.
GSK PLC
JOHNSON & JOHNSON SERVICES INC.
LILLY
MEDTRONIC
MERCK & CO. INC.
NOVARTIS AG
PFIZER INC.
TEVA PHARMACEUTICAL INDUSTRIES LTD.